Circulating Extracellular Vesicles As Biomarkers in the Diagnosis, Prognosis and Therapy of Cardiovascular Diseases

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Sep 24

PMID 39314768

Authors

Dominika Bernath-Nagy

Melek Sukran Kalinyaprak

Evangelos Giannitsis

Pal Abraham

Florian Leuschner

Norbert Frey

Jona Benjamin Krohn

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease (CVD) ranks among the primary contributors to worldwide mortality. Hence, the importance of constant research on new circulating biomarkers for the improvement of early diagnosis and prognostication of different CVDs and the development and refinement of therapeutic measures is critical. Extracellular vesicles (EV) have a great potential as diagnostic and prognostic markers, as they represent their parent cell by enclosing cell-specific molecules, which can differ in quality and quantity based on cell state. Assuming that all cell types of the cardiovascular system are capable of releasing EV into circulation, an emerging body of evidence has investigated the potential role of serum- or plasma-derived EV in CVD. Comprehensive research has unveiled alterations in EV quantity and EV-bound cargo in the form of RNA, proteins and lipids in the context of common CVDs such as coronary artery disease, atrial fibrillation, heart failure or inflammatory heart diseases, highlighting their diagnostic and prognostic relevance. In numerous and models, EV also showed promising therapeutic potential. However, translation of EV studies to a preclinical or clinical setting has proven to be challenging. This review is intended to provide an overview of the most relevant studies in the field of serum or plasma-derived EV.

References

Chen Y, Chen X, Li H, Li Y, Cheng D, Tang Y . Serum extracellular vesicles containing MIAT induces atrial fibrosis, inflammation and oxidative stress to promote atrial remodeling and atrial fibrillation via blockade of miR-485-5p-mediated CXCL10 inhibition. Clin Transl Med. 2021; 11(8):e482. PMC: 8329545. DOI: 10.1002/ctm2.482. View

Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D . European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary. Eur Heart J Qual Care Clin Outcomes. 2022; 8(4):377-382. DOI: 10.1093/ehjqcco/qcac014. View

Timmerman N, Waissi F, Dekker M, de Borst G, van Bennekom J, de Winter R . Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy. Sci Rep. 2022; 12(1):5521. PMC: 8975809. DOI: 10.1038/s41598-022-09225-6. View

Chirinos J, Castrellon A, Zambrano J, Jimenez J, Jy W, Horstman L . Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation. Heart Rhythm. 2005; 2(5):525-9. DOI: 10.1016/j.hrthm.2005.01.016. View

Liu P, Wang S, Li K, Yang Y, Man Y, Du F . Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction. Mol Med Rep. 2023; 27(6). PMC: 10206682. DOI: 10.3892/mmr.2023.13010. View

Oggero S, Godec T, van Gorp R, Pinto A, Schurgers L, Reutelingsperger C . Role of plasma extracellular vesicles in prediction of cardiovascular risk and alterations in response to statin therapy in hypertensive patients. J Hypertens. 2022; 40(8):1522-1529. PMC: 9415223. DOI: 10.1097/HJH.0000000000003178. View

Zhang X, Yang R, Ma M, Chen S, Guo K, Zhang L . Altered plasma exosome miRNAs and novel potential biomarkers in pediatric fulminant myocarditis. Genomics. 2023; 115(3):110622. DOI: 10.1016/j.ygeno.2023.110622. View

Gidlof O, Evander M, Rezeli M, Marko-Varga G, Laurell T, Erlinge D . Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone. Sci Rep. 2019; 9(1):8991. PMC: 6586849. DOI: 10.1038/s41598-019-45473-9. View

Bhatt A, Ambrosy A, Velazquez E . Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. Curr Cardiol Rep. 2017; 19(8):71. DOI: 10.1007/s11886-017-0876-4. View

10.

Masci P, Ganame J, Francone M, Desmet W, Lorenzoni V, Iacucci I . Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling. Eur Heart J. 2011; 32(13):1640-8. DOI: 10.1093/eurheartj/ehr064. View

11.

Lenart-Migdalska A, Drabik L, Kaznica-Wiatr M, Tomkiewicz-Pajak L, Podolec P, Olszowska M . Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran. Clin Appl Thromb Hemost. 2020; 26:1076029620972467. PMC: 7787695. DOI: 10.1177/1076029620972467. View

12.

Siwaponanan P, Kaewkumdee P, Phromawan W, Udompunturak S, Chomanee N, Udol K . Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation. J Transl Med. 2022; 20(1):4. PMC: 8722074. DOI: 10.1186/s12967-021-03213-6. View

13.

Bulut D, Becker V, Mugge A . Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. Can J Physiol Pharmacol. 2011; 89(4):239-44. DOI: 10.1139/y11-013. View

14.

Kajimoto T, Okada T, Miya S, Zhang L, Nakamura S . Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. Nat Commun. 2013; 4:2712. DOI: 10.1038/ncomms3712. View

15.

Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C . Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010; 107(5):677-84. DOI: 10.1161/CIRCRESAHA.109.215566. View

16.

Wang L, Liu J, Xu B, Liu Y, Liu Z . Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure. Kaohsiung J Med Sci. 2018; 34(11):626-633. DOI: 10.1016/j.kjms.2018.05.008. View

17.

Zheng M, Liu X, Han R, Yuan W, Sun K, Zhong J . Circulating exosomal long non-coding RNAs in patients with acute myocardial infarction. J Cell Mol Med. 2020; 24(16):9388-9396. PMC: 7417690. DOI: 10.1111/jcmm.15589. View

18.

Jayachandran M, Miller V, Heit J, Owen W . Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods. 2011; 375(1-2):207-14. PMC: 3253871. DOI: 10.1016/j.jim.2011.10.012. View

19.

Yao Y, He S, Wang Y, Cao Z, Liu D, Fu Y . Blockade of Exosome Release Suppresses Atrial Fibrillation by Alleviating Atrial Fibrosis in Canines With Prolonged Atrial Pacing. Front Cardiovasc Med. 2021; 8:699175. PMC: 8553970. DOI: 10.3389/fcvm.2021.699175. View

20.

Puelacher C, Lurati Buse G, Seeberger D, Sazgary L, Marbot S, Lampart A . Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization. Circulation. 2017; 137(12):1221-1232. DOI: 10.1161/CIRCULATIONAHA.117.030114. View